Strategy | Finance Blog
Healthcare Private Placement and M&A Transactions Review Week Ending April 9, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Mercy BioAnalytics: The company raised $41 million of Series A venture funding in a deal led by Novalis LifeSciences on April 3, 2023, putting the company's pre-money valuation at $81 million....
Consumer Private Placement and M&A Transactions Review Week Ending April 9, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Vytelle: The company raised $20 million of Series B venture funding in a deal led by Forage Capital Partners on April 3, 2023. Fulcrum Global Capital, Serra Ventures, KCRise Fund, Mountain...
Technology Private Placement and M&A Transactions Review Week Ending April 2, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Hygraph: The company raised EUR 27.6 million of Series B venture funding in a deal led by One Peak Partners on March 29, 2023. SquareOne, Peak, OpenOcean VC, and Boris Lokschin also...
Healthcare Private Placement and M&A Transactions Review Week Ending April 2, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions ArriVent Biopharma: The company raised $155 million of Series B venture funding in a deal led by Sofinnova Investments and General Catalyst on March 27, 2023, putting the company's pre-money...
Consumer Private Placement and M&A Transactions Review Week Ending April 2, 2023
Strategy | Financing Highlight Private Placement / Financing Transactions LesserEvil: The company received $19.1 million of development capital from undisclosed investors on March 27, 2023. The company is a producer of packaged organic and plant-based snacks....
Technology Private Placement and M&A Transactions Review Week Ending March 26 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Strangeworks: The company raised $29 million through a combination of Series A, and Series A1 venture funding in a deal led by Hitachi Ventures on March 21, 2023, putting the company's...
Healthcare Private Placement and M&A Transactions Review Week Ending March 26 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Flare Therapeutics: The company raised $123 million of Series B venture funding in a deal led by Pfizer Ventures and GordonMD Global Investments on March 22, 2023, putting the company's...
Consumer Private Placement and M&A Transactions Review Week Ending March 26 2023
Strategy | Financing Highlight Private Placement / Financing Transactions EarthOptics: The company raised $34.4 million of Series B venture funding in a deal led by Continental Grain Company on March 21, 2023, putting the company's pre-money valuation at $40.4...
Technology Private Placement and M&A Transactions Review Week Ending March 19 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Verity: The company raised CHF 30 million of Series B venture funding in a deal led by A.P. Moller Holding on March 14, 2023. Exor and other undisclosed investors also participated in the...
Healthcare Private Placement and M&A Transactions Review Week Ending March 19 2023
Strategy | Financing Highlight Private Placement / Financing Transactions Mediar Therapeutics: The company raised $85 million of Series A venture funding in a deal led by Novartis Venture Fund and Sofinnova Partners on March 15, 2023, putting the company's pre-money...